Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy

Wang, ZR; Cordova, LE; Chalasani, P; Lu, JQ

Lu, JQ (通讯作者),Univ Arizona, R Ken Coit Coll Pharm, Skaggs Pharmaceut Sci Ctr, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.;Lu, JQ (通讯作者),Univ Arizona, Comprehens Canc Ctr, NCI, Tucson, AZ 85721 USA.;Lu, JQ (通讯作者),Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA.;Lu, JQ (通讯作者),Univ Arizona, Southwest Environm Hlth Sci Ctr, Tucson, AZ 85721 USA.

MOLECULAR PHARMACEUTICS, 2022; 19 (12): 4665

Abstract

In this study, we focus on investigating the therapeutic effects of camptothesome on treating metastatic triple-negative breast cancer (TNBC). We eluc......

Full Text Link